NGM
Ngm Biopharmaceuticals Inc

1,273
Loading...
Loading...
News
all
press releases
Barrick Gold, NovaGold shares rise following sale of Donlin Gold stake
Investing.com -- Shares of Barrick Gold (NYSE:GOLD) Corp (TSX:ABX) edged up 1.2% while NovaGold Resources Inc (TSX:NG) soared 9.7% after Barrick announced the sale of its 50% interest in the Donlin Gold Project in Alaska. The stake held by Barrick’s subsidiary, Barrick Gold U.S. Inc., was sold to affiliates of Paulson Advisers LLC and NovaGold Resources Inc. for $1 billion in cash.
investing.com·5mo ago
News Placeholder
More News
News Placeholder
NGM Bio Announces Closing of Tender Offer
SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. ( NGM Bio ) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics...
Globe Newswire·1y ago
News Placeholder
Financial Contrast: NGM Biopharmaceuticals (NASDAQ:NGM) and AgeX Therapeutics (NYSE:AGE)
AgeX Therapeutics (NYSE:AGE Get Free Report) and NGM Biopharmaceuticals (NASDAQ:NGM Get Free Report) are both small-cap medical companies, but which is the superior stock? We will...
Zolmax·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI PR Newswire NEW YORK, March 22, 2024 NEW YORK, March 22...
PR Newswire·1y ago
News Placeholder
Kuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law Firm
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
Globe Newswire·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, NGM
NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Globe Newswire·1y ago
News Placeholder
NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...
Globe Newswire·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE PR Newswire NEW YORK, March 18, 2024 NEW YORK, March 18...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, NGM, SCTL
NEW YORK, March 16, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Globe Newswire·1y ago
News Placeholder
NGM Biopharmaceuticals (NASDAQ:NGM) Rating Lowered to Market Perform at Raymond James
Raymond James cut shares of NGM Biopharmaceuticals (NASDAQ:NGM Free Report) from an outperform rating to a market perform rating in a research note released on Tuesday, MarketBeat Ratings...
Ticker Report·1y ago

Latest NGM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.